In Precise Tumor, which tier indicates FDA-approved therapy in the same cancer?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Unlock essential insights into hereditary cancer risk, diagnosis, and treatment. Study comprehensive strategies with flashcards and multiple-choice questions featuring detailed explanations. Prepare effectively for your exam!

Multiple Choice

In Precise Tumor, which tier indicates FDA-approved therapy in the same cancer?

Explanation:
In Precise Tumor, tiers reflect how strong the evidence and regulatory approval are for a biomarker-directed therapy in a given cancer. Tier IA specifically means there is an FDA-approved therapy for this exact cancer, with the indication and labeling supporting use in the patient’s tumor type. This makes it the best choice because it represents a therapy that is approved for the same cancer and is typically considered standard of care when the biomarker is present, backed by robust clinical evidence. Other tiers cover therapies that may be FDA-approved but for a different cancer or context, or therapies supported by less direct or lower-quality evidence (such as non–FDA-approved uses, trials, or extrapolated data). So while those tiers can still be informative, they do not indicate an FDA-approved, same-cancer therapy in the way Tier IA does.

In Precise Tumor, tiers reflect how strong the evidence and regulatory approval are for a biomarker-directed therapy in a given cancer. Tier IA specifically means there is an FDA-approved therapy for this exact cancer, with the indication and labeling supporting use in the patient’s tumor type. This makes it the best choice because it represents a therapy that is approved for the same cancer and is typically considered standard of care when the biomarker is present, backed by robust clinical evidence.

Other tiers cover therapies that may be FDA-approved but for a different cancer or context, or therapies supported by less direct or lower-quality evidence (such as non–FDA-approved uses, trials, or extrapolated data). So while those tiers can still be informative, they do not indicate an FDA-approved, same-cancer therapy in the way Tier IA does.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy